ARBS: Q1 2025 revenue rose 21.6% year-over-year to €1.3 million, led by cosmetic raw material sales

About this update from Arterra Bioscience Spa

Revenue grew 21.6% year-over-year to €1.3 million in Q1 2025, driven by strong cosmetic raw material sales and services. Management remains confident in achieving annual targets, supported by robust order intake.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Arterra Bioscience Spa